American HealthCare Capital is pleased to introduce two dialysis facilities for sale in the Houston, Texas area. Established in 2015 and 2020, the companies are licensed by the Texas Health & Human Services Commission as End Stage Renal Disease (ESRD) facilities. The companies’ services primarily include in-center hemodialysis (HD) and on-site hemodialysis (HD) performed at skilled nursing facilities, and one company has recently implemented a home peritoneal dialysis (PD) program.
Payors include Medicare, Medicaid, Medicaid MCO, Commercial Insurance, and Private Pay. Insurance contracts include, but are not limited to, Aetna, BCBS, Humana, United, Amerigroup, Molina, and Superior. The companies maintain contracts with some insurance programs that are unique and difficult for new market entrants to acquire. On a combined basis, the companies generated gross revenues of $2,426,223 and a net income of $604,535 in 2020. In 2021, gross revenues were $2,113,888 with a net loss of ($302,960) in 2021. The loss in 2021 was due to the significant startup costs associated with opening the second dialysis facility, in addition to the negative effects of COVID. In 2022, the companies returned to profitability on a combined basis with gross revenues of $2,099,951 and adjusted EBITDA of $187,619 (8.93%). Through 6/30/23, the companies generated gross revenues of $953,741 and adjusted EBITDA of $182,292 (19.11%). The companies currently serve over 50 patients, and they expect additional growth via the recent expansion of the home PD program. On a combined basis, gross revenues are projected to reach $2,000,000 with adjusted EBITDA of approximately $365,000 by the end of 2023.
Over 20 employees and contractors are expected to remain with the company post-sale, and the sole owner, who is a Nephrologist, may be willing to stay.
The seller will consider competitive offers.
